Active recombinant kinases and associated substrates

Tuesday, 08 April, 2008 | Supplied by: http://www.biomol.com/Online_Catalog/Online_Catalog/Products/36/?categoryId=1019

It is established that amplification, mutation or misregulation of kinases contributes to many human diseases.

To facilitate further development of new kinase inhibitors, BIOMOL offers over 120 active recombinant kinases and associated substrates for inhibitor screening or selectivity studies. All kinases or substrates are also available in bulk.

New kinases include:

Glucokinase
SGK3
PKAc alpha
TRKA
TRKB
PKC theta

Amsbio CELLBANKER cryopreservation solutions

Each batch of Amsbio's CELLBANKER cryopreservation solution is manufactured under strict...

ProImmune ProVE SL Self-Loading MHC Class I Monomers

The novel reagents for antigen-specific CD8⁺ T cell detection are designed to offer...

HAWK Biosystems Quantifying Functions in Proteins (QF-Pro) reagent kits

HAWK Biosystems' Quantifying Functions in Proteins (QF-Pro) reagent kits contain the tailored...

Content from other channels on our network

Cutting-edge digital health tools putting plastic, silicon and steel to the sword

Electronic prescriptions and how they are used

Webinar: Turning data protection into a business advantage

Breastfeeding challenges healthcare professionals should be prepared to address

Dr Vinod Seetharaman appointed Dedalus ANZ Chief Medical Officer

Renewable fuel strategy to reduce emissions

TagEnergy to build a BESS at Golden Plains Wind Farm

Partnership brings innovative fuel solutions to Gippsland

Webinar: Turning data protection into a business advantage

How mandatory climate reporting is raising the bar for corporate leadership

Yume Food enters liquidation, sale process launched

Norco celebrates two years of ice cream making at its reopened factory

Meat processing tools on show at IPPE2026

Digital labelling trial proposal in NZ for certain imported food

Large-scale mixing plant for flavour production